|
 |
Biomediation > Antibody
The following information is about Antibody.
Antibody Defined
Any of the body globulins that combine specifically with antigens and neutralize toxins, agglutinate bacteria or cells, and precipitate soluble antigens.
This definition is in context to Biomediation. See more contextual defintions for Antibody.
Scientists use genetic engineering to make virus-resistant grapevines
Published July 3, 2009, 9:49 pm, New Kerala
Washington, July 3 : Scientists are making certain plants resistant to the 'Grapevine fanleaf virus' GFLV by genetic engineering.
Genetically modified vines avoid virus
Published July 3, 2009, 3:41 pm, redOrbit
Genetic engineering could make grapevines immune to a common virus that now results in smaller grapes and crop loss, German scientists said. Modified plants have produced antibodies against Grapevine fanleaf virus, caused by the vine louse, or rust mite, researchers at the Institute for Molecular Biology and Applied Ecology, in Aachen, said. These antibodies 'recognize' the viruses and prevent ...
Genetically modified vines avoid virus
Published July 3, 2009, 12:59 pm, UPI
AACHEN, Germany, July 3 (UPI) -- Genetic engineering could make grapevines immune to a common virus that now results in smaller grapes and crop loss, German scientists said.
New Targeted Therapy Finds And Eliminates Deadly Leukemia Stem Cells
Published July 2, 2009, 9:23 pm, Science Daily
New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia, a notoriously treatment-resistant blood cancer. The study describes exciting preclinical studies in which a new therapeutic approach selectively attacks human cancer cells grown in the lab and in animal models of leukemia.
Virus-resistant Grapevines
Published July 2, 2009, 10:47 am, redOrbit
Viruses can cost winegrowers an entire harvest. If they infest the grapevines, even pesticides are often no use. What’s more, these chemicals are harmful to the environment.
New targeted therapy finds and eliminates deadly leukemia stem cells
Published July 2, 2009, 9:13 am, EurekAlert!
( Cell Press ) New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia, a notoriously treatment-resistant blood cancer. The study, published by Cell Press in the July 2 issue of the journal Cell Stem Cell, describes exciting preclinical studies in which a new therapeutic approach selectively attacks human cancer cells grown in the lab ...
Virus-resistant grapevines
Published July 2, 2009, 8:18 am, PhysOrg
Viruses can cost winegrowers an entire harvest. If they infest the grapevines, even pesticides are often no use. What's more, these chemicals are harmful to the environment. Researchers are growing plants that produce antibodies against the viruses and are thus immune.
2009 Dr. Paul Janssen Award For Biomedical Research Won By Axel Ullrich
Published July 2, 2009, 8:09 am, Medical News Today
Johnson & Johnson has announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin® (trastuzumab) , is the winner of the 2009 Dr. Paul Janssen Award for Biomedical Research. An independent committee of world-renowned scientists selected Dr.
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
Published July 1, 2009, 11:30 am, redOrbit
LONDON, July 1 /PRNewswire/ -- Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin(R) (trastuzumab)*, is the winner of the 2009 Dr.
Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research
Published July 1, 2009, 10:14 am, EurekAlert!
( Porter Novelli ) Johnson & Johnson announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin (trastuzumab), is the winner of the 2009 Dr. Paul Janssen Award for Biomedical Research. An independent committee of world-renowned scientists ...
Are you looking for additional Biomediation > Antibody news? Try our new "Antibody News Focus" area.
Off-site Antibody Links, User Submitted
The following links have been collected through user bookmark submission in the Antibody category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Thu Jul 2
Sun Jun 28
- Cancer Treatment Found Effective in Animal Tests - NYTimes.com
- Monoclonal antibody production: Introduction: Monoclonal antibodies are monospecific antibodies that are identical because they are produced by one type of immune cell that are all clones of a single parent cell.
Thu Jun 25
Tue Jun 23
Mon Jun 15
Thu Jun 11
Tue Jun 9
- Custom antibody Synthesis: Bio-Synthesis has provided Custom antibody Synthesis, Polyclonal Antibody, Phosphospecifi c Antibody, Anti DNA Antibody, Antibody Diagnostics, Heterophile Antibody and Antibody Structure.
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Antibody. If you would like to find related tags we recommend Tag Patterns > Antibody
Off-site Antibody Research Links
If you still need additional information on Antibody then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Biomediation Topics
Everything you need to know about Biomediation
Biomediation
If you know the Biomediation Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Biomediation.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
License
This work is licensed under Creative Commons.